PORT WASHINGTON, NY – Aceto announced the acquisition of Syntor Fine Chemicals. Syntor is an asset-light manufacturer of fine chemicals for pharmaceutical and other life sciences end markets.

“The acquisition of Syntor is an important step in Aceto’s strategic growth plan,” said Gilles Cottier, Chief Executive Officer of Aceto. “Syntor’s synthesis and formulation capabilities enhance Aceto’s existing services and expand our value-added offerings in life sciences materials. With the addition of Syntor’s technical team, we can provide greater product customization in addition to supplying our current offering of high-quality, specialty materials.”

“We are very pleased and excited about our partnership with Aceto,” said Simon Knowles, Managing Partner of Syntor. “The two companies are well aligned in their culture and drive to maximize value to customers through sourcing and development of complex chemistries. We believe Syntor will thrive with the support of Aceto’s global infrastructure, and we look forward to contributing to the next stage of growth for the combined company.”

Syntor will operate under the name Syntor by Aceto, and it is intended that all employees will be retained in their current roles.  The combined entity will leverage the increased scale of Syntor and Aceto to provide enhanced value to customers. 

Founded in 1947, Aceto is a leading global virtual manufacturer supplying niche, differentiated specialty materials in life sciences and advanced technology end markets. With business operations in nine countries, Aceto distributes over 1,100 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries.

Founded in 2004 and headquartered in Runcorn, U.K., Syntor Fine Chemicals develops and supplies fine chemicals for life sciences and other advanced technology end markets.